The Journal of allergy and clinical immunology
PrecISE: Precision Medicine in Severe Asthma An Adaptive Platform Trial with Biomarker Ascertainment.
Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: results from SARP-3.
NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity.
A deoxyribonuclease 1-like 3 genetic variant associates with asthma exacerbations.
A genome-wide association study of asthma hospitalizations in adults.
Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways.
Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma.
Baseline sputum eosinophil+neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) Cohort.
An Expert Consensus Framework for Asthma Remission as a Treatment Goal.
Atopic dermatitis, race, and genetics.
